Year |
Citation |
Score |
2023 |
Deshpande SH, Bagewadi ZK, Khan TMY, Mahnashi MH, Shaikh IA, Alshehery S, Khan AA, Patil VS, Roy S. Exploring the Potential of Phytocompounds for Targeting Epigenetic Mechanisms in Rheumatoid Arthritis: An In Silico Study Using Similarity Indexing. Molecules (Basel, Switzerland). 28. PMID 36985402 DOI: 10.3390/molecules28062430 |
0.46 |
|
2014 |
Sodji Q, Patil V, Jain S, Kornacki JR, Mrksich M, Tekwani BL, Oyelere AK. The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors Bioorganic and Medicinal Chemistry Letters. 24: 4826-4830. PMID 25240614 DOI: 10.1016/J.Bmcl.2014.08.060 |
0.784 |
|
2013 |
Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK. Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors. Journal of Medicinal Chemistry. 56: 9969-81. PMID 24304348 DOI: 10.1021/Jm401225Q |
0.799 |
|
2013 |
Gryder BE, Rood MK, Johnson KA, Patil V, Raftery ED, Yao LP, Rice M, Azizi B, Doyle DF, Oyelere AK. Histone deacetylase inhibitors equipped with estrogen receptor modulation activity. Journal of Medicinal Chemistry. 56: 5782-96. PMID 23786452 DOI: 10.1021/Jm400467W |
0.778 |
|
2013 |
Guerrant W, Patil V, Canzoneri JC, Yao LP, Hood R, Oyelere AK. Dual-acting histone deacetylase-topoisomerase I inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 3283-7. PMID 23622981 DOI: 10.1016/J.Bmcl.2013.03.108 |
0.749 |
|
2013 |
Patil V, Sodji QH, Kornacki JR, Mrksich M, Oyelere AK. 3-Hydroxypyridin-2-thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition Journal of Medicinal Chemistry. 56: 3492-3506. PMID 23547652 DOI: 10.1021/Jm301769U |
0.771 |
|
2012 |
Patil V, Canzoneri JC, Samatov TR, Lührmann R, Oyelere AK. Molecular architecture of zinc chelating small molecules that inhibit spliceosome assembly at an early stage. Rna (New York, N.Y.). 18: 1605-11. PMID 22832025 DOI: 10.1261/Rna.034819.112 |
0.772 |
|
2012 |
Guerrant W, Patil V, Canzoneri JC, Oyelere AK. Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors. Journal of Medicinal Chemistry. 55: 1465-77. PMID 22260166 DOI: 10.1021/Jm200799P |
0.751 |
|
2010 |
Mwakwari SC, Guerrant W, Patil V, Khan SI, Tekwani BL, Gurard-Levin ZA, Mrksich M, Oyelere AK. Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton Journal of Medicinal Chemistry. 53: 6100-6111. PMID 20669972 DOI: 10.1021/Jm100507Q |
0.804 |
|
2010 |
Mwakwari SC, Patil V, Guerrant W, Oyelere AK. Macrocyclic histone deacetylase inhibitors. Current Topics in Medicinal Chemistry. 10: 1423-40. PMID 20536416 DOI: 10.2174/156802610792232079 |
0.807 |
|
2010 |
Patil V, Guerrant W, Chen PC, Gryder B, Benicewicz DB, Khan SI, Tekwani BL, Oyelere AK. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. Bioorganic & Medicinal Chemistry. 18: 415-25. PMID 19914074 DOI: 10.1016/J.Bmc.2009.10.042 |
0.748 |
|
2008 |
Chen PC, Patil V, Guerrant W, Green P, Oyelere AK. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. Bioorganic & Medicinal Chemistry. 16: 4839-53. PMID 18397827 DOI: 10.1016/J.Bmc.2008.03.050 |
0.796 |
|
Show low-probability matches. |